Cost-Effectiveness of Nivolumab in Patients with Advanced or Metastatic Renal Cell Carcinoma in Portugal
Abstract
Authors
K Verleger AJ Almeida B Verheggen O Schoeman S Klijn J Doan M Lees B Malcolm
K Verleger AJ Almeida B Verheggen O Schoeman S Klijn J Doan M Lees B Malcolm
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now